Long-term efficacy and safety of romiplostim in refractory aplastic anemia : follow-up of a phase 2/3 study
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:8 |
|---|---|
| Enthalten in: |
Blood advances - 8(2024), 6 vom: 26. März, Seite 1415-1419 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Mitani, Kinuko [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
9014-42-0 |
|---|
| Anmerkungen: |
Date Completed 15.03.2024 Date Revised 23.03.2024 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1182/bloodadvances.2023010959 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM366249657 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM366249657 | ||
| 003 | DE-627 | ||
| 005 | 20240323234849.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231227s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1182/bloodadvances.2023010959 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1342.xml |
| 035 | |a (DE-627)NLM366249657 | ||
| 035 | |a (NLM)38134300 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Mitani, Kinuko |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Long-term efficacy and safety of romiplostim in refractory aplastic anemia |b follow-up of a phase 2/3 study |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 15.03.2024 | ||
| 500 | |a Date Revised 23.03.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Clinical Trial, Phase III | |
| 650 | 4 | |a Clinical Trial, Phase II | |
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a romiplostim |2 NLM | |
| 650 | 7 | |a GN5XU2DXKV |2 NLM | |
| 650 | 7 | |a Recombinant Fusion Proteins |2 NLM | |
| 650 | 7 | |a Thrombopoietin |2 NLM | |
| 650 | 7 | |a 9014-42-0 |2 NLM | |
| 650 | 7 | |a Receptors, Fc |2 NLM | |
| 700 | 1 | |a Lee, Jong Wook |e verfasserin |4 aut | |
| 700 | 1 | |a Jang, Jun Ho |e verfasserin |4 aut | |
| 700 | 1 | |a Tomiyama, Yoshiaki |e verfasserin |4 aut | |
| 700 | 1 | |a Miyazaki, Koji |e verfasserin |4 aut | |
| 700 | 1 | |a Nagafuji, Koji |e verfasserin |4 aut | |
| 700 | 1 | |a Usuki, Kensuke |e verfasserin |4 aut | |
| 700 | 1 | |a Uoshima, Nobuhiko |e verfasserin |4 aut | |
| 700 | 1 | |a Fujisaki, Tomoaki |e verfasserin |4 aut | |
| 700 | 1 | |a Kosugi, Hiroshi |e verfasserin |4 aut | |
| 700 | 1 | |a Matsumura, Itaru |e verfasserin |4 aut | |
| 700 | 1 | |a Sasaki, Ko |e verfasserin |4 aut | |
| 700 | 1 | |a Kizaki, Masahiro |e verfasserin |4 aut | |
| 700 | 1 | |a Sawa, Masashi |e verfasserin |4 aut | |
| 700 | 1 | |a Hidaka, Michihiro |e verfasserin |4 aut | |
| 700 | 1 | |a Kobayashi, Naoki |e verfasserin |4 aut | |
| 700 | 1 | |a Ichikawa, Satoshi |e verfasserin |4 aut | |
| 700 | 1 | |a Yonemura, Yuji |e verfasserin |4 aut | |
| 700 | 1 | |a Murotani, Kenta |e verfasserin |4 aut | |
| 700 | 1 | |a Shimizu, Mami |e verfasserin |4 aut | |
| 700 | 1 | |a Matsuda, Akira |e verfasserin |4 aut | |
| 700 | 1 | |a Ozawa, Keiya |e verfasserin |4 aut | |
| 700 | 1 | |a Nakao, Shinji |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Blood advances |d 2016 |g 8(2024), 6 vom: 26. März, Seite 1415-1419 |w (DE-627)NLM268683263 |x 2473-9537 |7 nnns |
| 773 | 1 | 8 | |g volume:8 |g year:2024 |g number:6 |g day:26 |g month:03 |g pages:1415-1419 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1182/bloodadvances.2023010959 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 8 |j 2024 |e 6 |b 26 |c 03 |h 1415-1419 | ||